Kurt Stoeckli to head Glenmark’s global research portfolio

Based out of Switzerland, Stoeckli will lead Glenmark’s global research portfolio, including biologics (NBEs) and small molecules (NCEs), the company stated in a release on Bombay Stock Exchange.